-
2024-518146-25-00
patients with atrial fibrillation and preserved left ve 5
-
2025-524955-30-01
Cardiovascular diseases 11
-
2024-519737-30-00
Roux-en-Y gastric bypass 6
-
2024-518653-41-00
Patients with giant cell arteritis (= Horton’s disease) 5
-
2025-523349-86-00
Acute Myocardial Infarction 5
-
2025-522060-32-00
STEMI (ST elevated Myocardial Infarction) 4
-
2024-516731-27-00
Ischemic stroke patients with secondary post-rtPA hypof 5
-
2024-519749-31-00
Hypertension 6
-
2025-520929-20-00
PACEMAKER IN ANTICOAGULATED PATIENTS 5
-
2025-520937-22-00
advanced chronic ischemia (fontaine III-IV class and Ru 4
-
2025-525053-39-00
Coronary artery disease 5
-
2024-520324-29-00
Atherosclerotic cardiovascular disease 4
-
2025-523374-17-03
Type 2 diabetes 6
-
2025-523375-29-00
Myocardial Infarction 5
-
2025-520954-12-00
Atrial Fibrillation
Device thrombosis post-Left Atrial 6
-
2024-517688-21-00
Recurrent Pericarditis 5
-
2025-524110-28-00
Incidental Subsegmental Pulmonary Embolism in cancer pa 6
-
2024-517699-39-00
high /medium risk cardiac surgery 5
-
2025-520969-51-00
Heart failure with preserved ejection fraction 6
-
2024-519224-24-00
Following heart surgery, patients experience poor posto 6
-
2025-525121-13-00
Coronary artery disease 6
-
2024-512350-17-01
Patients with coronary artery disease and an indication 6
-
2024-513310-36-01
Transthyretin amyloid cardiomyopathy 6
-
2024-518706-41-01
Cardiovascular disease 5